Zheng J - Search Results

1

[Clinicopathological features associated with EGFR gene mutation in non-small cell lung cancer patients].

Zhou J, Mo W, Zhao J, Zheng J, Ding W, Zhou J. Zhou J, et al. Among authors: zheng j. Zhonghua Yi Xue Za Zhi. 2014 Aug 13;94(30):2332-6. Zhonghua Yi Xue Za Zhi. 2014. PMID: 25399972 Chinese.

2

Prognostic impact of Raf-1 and p-Raf-1 expressions for poor survival rate in non-small cell lung cancer.

Qiu ZX, Wang L, Han J, Liu D, Huang W, Altaf K, Qiu XS, Javed MA, Zheng J, Chen BJ, Li WM. Qiu ZX, et al. Among authors: zheng j. Cancer Sci. 2012 Oct;103(10):1774-9. doi: 10.1111/j.1349-7006.2012.02375.x. Epub 2012 Aug 8. Cancer Sci. 2012. PMID: 22738312 Free PMC article.

3

Accurate and economical detection of ALK positive lung adenocarcinoma with semiquantitative immunohistochemical screening.

Zhou J, Zhao J, Sun K, Wang B, Wang L, Chen X, Zheng J, You Q, Wang X, Ding W, Zhou J. Zhou J, et al. Among authors: zheng j. PLoS One. 2014 Mar 25;9(3):e92828. doi: 10.1371/journal.pone.0092828. eCollection 2014. PLoS One. 2014. PMID: 24667320 Free PMC article. Clinical Trial.

4

Poor response to gefitinib in lung adenocarcinoma with concomitant epidermal growth factor receptor mutation and anaplastic lymphoma kinase rearrangement.

Zhou J, Zheng J, Zhao J, Sheng Y, Ding W, Zhou J. Zhou J, et al. Among authors: zheng j. Thorac Cancer. 2015 Mar;6(2):216-9. doi: 10.1111/1759-7714.12146. Epub 2015 Mar 2. Thorac Cancer. 2015. PMID: 26273361 Free PMC article.

5

Gene status and clinicopathologic characteristics of lung adenocarcinomas with mediastinal lymph node metastasis.

Zhang S, Yan B, Zheng J, Zhao J, Zhou J. Zhang S, et al. Among authors: zheng j. Oncotarget. 2016 Sep 27;7(39):63758-63766. doi: 10.18632/oncotarget.11494. Oncotarget. 2016. PMID: 27563816 Free PMC article.

6

A Prediction Model for ROS1-Rearranged Lung Adenocarcinomas based on Histologic Features.

Zhou J, Zhao J, Zheng J, Kong M, Sun K, Wang B, Chen X, Ding W, Zhou J. Zhou J, et al. Among authors: zheng j. PLoS One. 2016 Sep 20;11(9):e0161861. doi: 10.1371/journal.pone.0161861. eCollection 2016. PLoS One. 2016. PMID: 27648828 Free PMC article.

7

Advanced lung adenocarcinomas with ROS1-rearrangement frequently show hepatoid cell.

Zhao J, Zheng J, Kong M, Zhou J, Ding W, Zhou J. Zhao J, et al. Among authors: zheng j. Oncotarget. 2016 Nov 8;7(45):74162-74170. doi: 10.18632/oncotarget.12364. Oncotarget. 2016. PMID: 27708233 Free PMC article.

8

Significant Radiologic Response of Pancreatic Metastasis After Targeted Therapy of Ceritinib (LDK378) for ALK-Rearranged Lung Adenocarcinoma Presenting With Hyperglycemia.

Zheng J, Zhou J, Zhu Y, Shen Q, Zhou J. Zheng J, et al. Oncol Res. 2017 Apr 14;25(4):545-550. doi: 10.3727/096504016X14801968368898. Oncol Res. 2017. PMID: 28438234 Free PMC article.

9

Crizotinib in patients with anaplastic lymphoma kinase-positive advanced non-small cell lung cancer versus chemotherapy as a first-line treatment.

Zhou J, Zheng J, Zhang X, Zhao J, Zhu Y, Shen Q, Wang Y, Sun K, Zhang Z, Pan Z, Shen Y, Zhou J. Zhou J, et al. Among authors: zheng j. BMC Cancer. 2018 Jan 3;18(1):10. doi: 10.1186/s12885-017-3720-8. BMC Cancer. 2018. PMID: 29298713 Free PMC article.

10

A genomic and clinicopathological study of non-small-cell lung cancers with discordant ROS1 gene status by fluorescence in-situ hybridisation and immunohistochemical analysis.

Zhao J, Chen X, Zheng J, Kong M, Wang B, Ding W. Zhao J, et al. Among authors: zheng j. Histopathology. 2018 Jul;73(1):19-28. doi: 10.1111/his.13492. Epub 2018 Apr 17. Histopathology. 2018. PMID: 29464758

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24,031 results

Search Page

Filters